Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/23/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/19/16 | 8-K | Current report filing |
|
36 | |
| 05/16/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
42 |
| 04/26/16 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
23 | |
| 04/21/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/01/16 | 8-K | Current report filing |
|
14 | |
| 03/31/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
307 |
| 03/31/16 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
4 | |
| 03/11/16 | 8-K | Current report filing |
|
4 | |
| 02/23/16 | 8-K | Current report filing |
|
4 |
